FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018348575> ?p ?o ?g. }

• W2018348575 endingPage "602" @default.
• W2018348575 startingPage "598" @default.
• W2018348575 abstract "To determine whether mycophenolate mofetil (MMF) has beneficial effects on refractory idiopathic thrombocytopenic purpura (ITP) and the corresponding cellular mechanism. Twenty refractory ITP patients resistant to corticosteroid and/or splenectomy and chemical therapy were given MMF 1.5-2.0 g/d orally for a 2 to 4-month period. Serum immunoglobulin was detected by rate nephelometry. Platelet-associated antibodies (PAIgG) were assayed by enzyme-linked immunosorbant assay. The immunophenotypic analysis was performed on a flow cytometer and cell apoptosis was detected with transferase mediated dUTP biotin nick end labeling (TUNEL) method. Sixteen of the 20 (80%) patients had responses to MMF treatment; 9 (45%) achieved a complete response, 4 (20%) achieved a partial response, and 3 (15%) achieved a minor response. The therapeutic effects were found to be better in male patients than female patients. The number of CD3+ peripheral blood cells (PBCs) and CD4+ PBCs increased and the number of CD8+ PBCs decreased. The plasma level of IgG, IgM, IgA and platelet associated IgG (PAIgG) decreased in 86% of the patients. TUNEL assay showed that mycophenolate acid (MPA) 0.1 mmol/L induced apoptosis of peripheral blood mononuclear cells isolated from refractory ITP patients. The apoptosis rate was increased in male patients after treatment with MPA, but was unchanged in female patients. Therapy for a period of 8 to 16 weeks with mediandose of MMF was valuable for the treatment of refractory ITP." @default.
• W2018348575 created "2016-06-24" @default.
• W2018348575 creator A5001858255 @default.
• W2018348575 creator A5014662367 @default.
• W2018348575 creator A5016890292 @default.
• W2018348575 creator A5019619645 @default.
• W2018348575 creator A5022176584 @default.
• W2018348575 creator A5027221116 @default.
• W2018348575 creator A5073723493 @default.
• W2018348575 creator A5089363242 @default.
• W2018348575 date "2005-05-01" @default.
• W2018348575 modified "2023-10-02" @default.
• W2018348575 title "Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura" @default.
• W2018348575 cites W1499721021 @default.
• W2018348575 cites W1976472818 @default.
• W2018348575 cites W1979651647 @default.
• W2018348575 cites W2018768428 @default.
• W2018348575 cites W2035004724 @default.
• W2018348575 cites W2053265441 @default.
• W2018348575 cites W2054404003 @default.
• W2018348575 cites W2054901200 @default.
• W2018348575 cites W2058437162 @default.
• W2018348575 cites W2059792800 @default.
• W2018348575 cites W2063950330 @default.
• W2018348575 cites W2071499539 @default.
• W2018348575 cites W2124669347 @default.
• W2018348575 cites W2324505043 @default.
• W2018348575 cites W4242463402 @default.
• W2018348575 doi "https://doi.org/10.1111/j.1745-7254.2005.00088.x" @default.
• W2018348575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15842780" @default.
• W2018348575 hasPublicationYear "2005" @default.
• W2018348575 type Work @default.
• W2018348575 sameAs 2018348575 @default.
• W2018348575 citedByCount "34" @default.
• W2018348575 countsByYear W20183485752012 @default.
• W2018348575 countsByYear W20183485752013 @default.
• W2018348575 countsByYear W20183485752015 @default.
• W2018348575 countsByYear W20183485752016 @default.
• W2018348575 countsByYear W20183485752018 @default.
• W2018348575 countsByYear W20183485752019 @default.
• W2018348575 countsByYear W20183485752020 @default.
• W2018348575 countsByYear W20183485752021 @default.
• W2018348575 countsByYear W20183485752022 @default.
• W2018348575 countsByYear W20183485752023 @default.
• W2018348575 crossrefType "journal-article" @default.
• W2018348575 hasAuthorship W2018348575A5001858255 @default.
• W2018348575 hasAuthorship W2018348575A5014662367 @default.
• W2018348575 hasAuthorship W2018348575A5016890292 @default.
• W2018348575 hasAuthorship W2018348575A5019619645 @default.
• W2018348575 hasAuthorship W2018348575A5022176584 @default.
• W2018348575 hasAuthorship W2018348575A5027221116 @default.
• W2018348575 hasAuthorship W2018348575A5073723493 @default.
• W2018348575 hasAuthorship W2018348575A5089363242 @default.
• W2018348575 hasBestOaLocation W20183485751 @default.
• W2018348575 hasConcept C126322002 @default.
• W2018348575 hasConcept C137061746 @default.
• W2018348575 hasConcept C142424586 @default.
• W2018348575 hasConcept C159654299 @default.
• W2018348575 hasConcept C167672396 @default.
• W2018348575 hasConcept C196795494 @default.
• W2018348575 hasConcept C202751555 @default.
• W2018348575 hasConcept C203014093 @default.
• W2018348575 hasConcept C204232928 @default.
• W2018348575 hasConcept C2779771385 @default.
• W2018348575 hasConcept C2909935303 @default.
• W2018348575 hasConcept C2911091166 @default.
• W2018348575 hasConcept C55493867 @default.
• W2018348575 hasConcept C71924100 @default.
• W2018348575 hasConcept C86803240 @default.
• W2018348575 hasConcept C87355193 @default.
• W2018348575 hasConcept C8891405 @default.
• W2018348575 hasConcept C89560881 @default.
• W2018348575 hasConcept C90924648 @default.
• W2018348575 hasConceptScore W2018348575C126322002 @default.
• W2018348575 hasConceptScore W2018348575C137061746 @default.
• W2018348575 hasConceptScore W2018348575C142424586 @default.
• W2018348575 hasConceptScore W2018348575C159654299 @default.
• W2018348575 hasConceptScore W2018348575C167672396 @default.
• W2018348575 hasConceptScore W2018348575C196795494 @default.
• W2018348575 hasConceptScore W2018348575C202751555 @default.
• W2018348575 hasConceptScore W2018348575C203014093 @default.
• W2018348575 hasConceptScore W2018348575C204232928 @default.
• W2018348575 hasConceptScore W2018348575C2779771385 @default.
• W2018348575 hasConceptScore W2018348575C2909935303 @default.
• W2018348575 hasConceptScore W2018348575C2911091166 @default.
• W2018348575 hasConceptScore W2018348575C55493867 @default.
• W2018348575 hasConceptScore W2018348575C71924100 @default.
• W2018348575 hasConceptScore W2018348575C86803240 @default.
• W2018348575 hasConceptScore W2018348575C87355193 @default.
• W2018348575 hasConceptScore W2018348575C8891405 @default.
• W2018348575 hasConceptScore W2018348575C89560881 @default.
• W2018348575 hasConceptScore W2018348575C90924648 @default.
• W2018348575 hasIssue "5" @default.
• W2018348575 hasLocation W20183485751 @default.
• W2018348575 hasLocation W20183485752 @default.
• W2018348575 hasOpenAccess W2018348575 @default.
• W2018348575 hasPrimaryLocation W20183485751 @default.
• W2018348575 hasRelatedWork W1977622421 @default.

• next